Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALFAUR: Alfuzosin for Acute Urinary Retention
NCT00290030Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2001
- Primary completion
- Oct 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in acute urinary retention comparing Alfuzosin with Placebo (2 arms). Primary endpoints: Successful voiding in initial period (using an active voiding trial), No relapse during the 6 month treatment period and 1 more. Started May 2001; status: completed.
02
Drugs
alfuzosin
03
Conditions
acute urinary retention
Beyond the preview
Go deeper on NCT00290030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290030.